Literature DB >> 12087634

The use of alternative medicine in the treatment of hepatitis C.

Pamela Bean1.   

Abstract

More than one-third of Americans use herbs for health purposes, yet patients and physicians usually lack accurate information about safety and efficacy of herbal remedies. In recent years, there has been a substantial increase in the use of so-called complementary and alternative therapies by patients with liver disease. Medical professionals and laboratorians need to be informed about popular alternative therapies and be open-minded to the possibility that some benefit may come from some therapies currently regarded as alternative. Silymarin extracted from the milk thistle is most widely subscribed to as a remedy for liver diseases. The beneficial effects of silymarin are most often seen in the patients who had cirrhosis as a result of alcohol abuse. An ongoing clinical trial will provide some insight as to whether milk thistle directly affects HCV. Silymarin has a good safety record and only rare case reports of gastrointestinal disturbances and allergic skin rashes have been published. The active component of licorice root, glycyrrhizin, has been shown to reduce alanine transaminase and aspartate transaminase values in the serum. This protective function has recently been explained as the inhibitory effects of glycyrrhizin on immune-mediated cytotoxicity against hepatocytes and on nuclear factor (NF)-kappa B, which activates genes encoding inflammatory cytokines in the liver. Finally, some patients with hepatitis C take St. John's Wort and ginger to treat the side effects caused by interferon therapy. An excellent review of this subject was recently published by the NCCAM.

Entities:  

Mesh:

Year:  2002        PMID: 12087634

Source DB:  PubMed          Journal:  Am Clin Lab        ISSN: 1041-3235


  11 in total

1.  A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations.

Authors:  A Federico; M Trappoliere; C Tuccillo; I de Sio; A Di Leva; C Del Vecchio Blanco; C Loguercio
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

2.  Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model.

Authors:  Rosanna Di Paola; Marta Menegazzi; Emanuela Mazzon; Tiziana Genovese; Concetta Crisafulli; Martina Dal Bosco; Zhenzhen Zou; Hisanori Suzuki; Salvatore Cuzzocrea
Journal:  Intensive Care Med       Date:  2008-10-25       Impact factor: 17.440

3.  Complementary and alternative medicine use by patients chronically infected with hepatitis C virus.

Authors:  Colin P White; Gerilynn Hirsch; Sunil Patel; Fatin Adams; Kevork M Peltekian
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

4.  The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study.

Authors:  Carmela Loguercio; Alessandro Federico; Marco Trappoliere; Concetta Tuccillo; Ilario de Sio; Agnese Di Leva; Marco Niosi; Mauro Valeriano D'Auria; Rita Capasso; Camillo Del Vecchio Blanco
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

5.  Safety and efficacy of Qurse-e-istisqua in chronic hepatitis C infection: an exploratory study.

Authors:  Harmeet Singh Rehan; Deepti Chopra; Madhur Yadav; Neeta Wardhan; Seema Manak; K M Siddiqui; Mohd Aslam
Journal:  Indian J Pharmacol       Date:  2015 Jan-Feb       Impact factor: 1.200

6.  Amelioration of oxidative DNA damage in mouse peritoneal macrophages by Hippophae salicifolia due to its proton (H(+)) donation capability: Ex vivo and in vivo studies.

Authors:  Mainak Chakraborty; Indrajit Karmakar; Sagnik Haldar; Avratanu Das; Asis Bala; Pallab Kanti Haldar
Journal:  J Pharm Bioallied Sci       Date:  2016 Jul-Sep

7.  Hepatoprotective role of Legalon 70 against hydrogen peroxide in chickens.

Authors:  Samera M Alkatib; May K Ismail; Alaa H AlMoula; Intesar R Alkennany
Journal:  Int J Health Sci (Qassim)       Date:  2019 Jul-Aug

8.  A survey of Chinese herbal ingredients with liver protection activities.

Authors:  Rubin Wang; John Kong; Dali Wang; Linda Lin-min Lien; Eric Jung-chi Lien
Journal:  Chin Med       Date:  2007-05-10       Impact factor: 5.455

Review 9.  A current update on the rule of alternative and complementary medicine in the treatment of liver diseases.

Authors:  Yong-Song Guan; Qing He
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-10       Impact factor: 2.629

10.  Evaluation of the Antibacterial Efficacy of Azadirachta Indica, Commiphora Myrrha, Glycyrrhiza Glabra Against Enterococcus Faecalis using Real Time PCR.

Authors:  Suresh Anand; Mathan Rajan; Nagendrababu Venkateshbabu; Deivanayagam Kandaswamy; Yarramreddy Shravya; Kalaiselvam Rajeswari
Journal:  Open Dent J       Date:  2016-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.